Overview
Stimalia is a bioelectronic medicine company offering TraumaTone, described as the world's first percutaneous bioelectronic implant for PTSD. The device is designed to address treatment-resistant cases by modulating the body's alarm system through stellate ganglion targeting.
Key people
Something wrong or missing? Send an update. Fixed within 24 hours.